calendar
4,584 catalysts · 4,494 phase readout · 2,304 8k filing · 282 earnings · 172 phase 2 completion · 90 pdufa · 73 phase 1 completion
next 91 dayslessmore
MonWedFri
4,584 catalysts · 4,494 phase readout · 2,304 8k filing · 282 earnings · 172 phase 2 completion · 90 pdufa · 73 phase 1 completion
Sponsor: Edwards Lifesciences. Phase: NA. Conditions: Aortic Stenosis
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Colorectal Cancer
Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Multiple Myeloma
Sponsor: Fondazione Don Carlo Gnocchi Onlus. Phase: NA. Conditions: Critical Illness, Post Intensive Care Syndrome (PICS), Cardiopathy
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: DOCK8 Deficiency
Sponsor: Murdoch Childrens Research Institute. Phase: NA. Conditions: Mental Health, Depression and Burden in Caregivers, Anxiety Depression, Stress, Caregiver Anxiety, Parent of Child With Chronic Life-threatening Illness
Sponsor: Wake Forest University Health Sciences. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma
Sponsor: University of Milano Bicocca. Phase: . Conditions: Mechanical Ventilation, Acute Brain Injury
Sponsor: University Hospital, Ghent. Phase: . Conditions: Cardiac Arrest (CA), Out-of-hospital Cardiac Arrest (OHCA), Resuscitated Sudden Cardiac Death
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd.. Phase: . Conditions: Tetanus
Sponsor: ENBIOSIS BIOTECHNOLOGIES. Phase: NA. Conditions: Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD), Colitis
Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd. Phase: PHASE1. Conditions: Acute Pain
Sponsor: Zhujiang Hospital. Phase: . Conditions: Metabolic Dysfunction-associated Fatty Liver Disease
Sponsor: Janssen Sciences Ireland UC. Phase: PHASE3. Conditions: HIV Infections, HIV-1
Sponsor: Kevin Hill. Phase: PHASE3. Conditions: Congenital Heart Disease in Children, Inflammatory Response
Sponsor: RenJi Hospital. Phase: . Conditions: Advanced Breast Cancer
Sponsor: Kirsehir Ahi Evran Universitesi. Phase: . Conditions: Near-Infrared Spectroscopy
Sponsor: Rinri Therapeutics. Phase: PHASE1. Conditions: Sensorineural Hearing Loss, Presbyacusis, Auditory Neuropathy
Sponsor: Blueprint Medicines Corporation. Phase: . Conditions: Indolent Systemic Mastocytosis
Sponsor: BioArctic AB. Phase: PHASE2. Conditions: Parkinson Disease, Multiple System Atrophy
Sponsor: King's College London. Phase: NA. Conditions: Autism, Autism in Children
Sponsor: Hospital Universitari de Bellvitge. Phase: . Conditions: Intubated ICU Patients, Ventilator Associated Pneumonia ( VAP), Immunoparalysis
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Parathyroid Cancer, Primary Hyperparathyroidism, Pseudohypoparathyroidism, Inheritable Bone Diseases, Multiple Endocrine Neoplasia, Type 1
Sponsor: Riphah International University. Phase: NA. Conditions: Diabetic Neuropathies
Sponsor: ACADIA Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Alzheimer's Disease Psychosis
Sponsor: Anasonic. Phase: NA. Conditions: Chronic Kidney Disease
Sponsor: Karolinska Institutet. Phase: . Conditions: Anesthesia Complication, Tracheostomy Complications, Children Receiving General Anesthesia
Sponsor: University of Wuerzburg. Phase: . Conditions: Adrenocortical Carcinoma, Cushing's Syndrome
Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Carcinoma, Hepatocellular
Sponsor: University Hospital, Lille. Phase: PHASE2. Conditions: Crohn's Ileocolitis
Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Healthy Volunteer
Sponsor: Universidad Europea de Madrid. Phase: NA. Conditions: Muscle Tone, Healthy Adult
Sponsor: Shaheed Mohtarma Benazir Bhutto Institue of Trauma. Phase: NA. Conditions: HEMODYNAMIC RESPONSETO LYRANGOSCOPY AND ENDOTRACHEAL INTUBATION
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Nasopharyngeal Carcinoma
Sponsor: King's College London. Phase: NA. Conditions: Depression Disorders
Sponsor: Seagen, a wholly owned subsidiary of Pfizer. Phase: PHASE1. Conditions: Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Pancreatic Ductal Adenocarcinoma
Sponsor: Cabaletta Bio. Phase: PHASE2. Conditions: Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome, Immune-Mediated Necrotizing Myopathy, Juvenile Dermatomyositis, Juvenile Polymyositis, Juvenile Idiopathic Inflammatory Myopathy (JIIM), Juvenile Myositis
Sponsor: Duke University. Phase: NA. Conditions: Hypertension, Insomnia
Sponsor: Kafrelsheikh University. Phase: . Conditions: Gastric Residual Volume, Aspiration Risk, Metoclopramide, Fasted Diabetic Patients, Elective Surgery
Sponsor: Daihong Liu. Phase: PHASE2. Conditions: GVHD, Acute, Stem Cell Transplant Complications
Sponsor: University Hospital Freiburg. Phase: NA. Conditions: Treatment-resistant Depression
Sponsor: MODAG GmbH. Phase: EARLY_PHASE1. Conditions: Multiple System Atrophy (MSA), Healthy Adult, Parkinson Disease
Sponsor: Chiang Mai University. Phase: . Conditions: Gestational Diabetes
Sponsor: Mayo Clinic. Phase: NA. Conditions: Insulin Resistance
Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE4. Conditions: Rheumatoid Arthritis
Sponsor: University of California, San Francisco. Phase: PHASE1. Conditions: Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation, ATM Gene Mutation, PALB2 Gene Mutation
Sponsor: The University of Texas Health Science Center at San Antonio. Phase: . Conditions: Lung Neoplasm
Sponsor: Spaulding Rehabilitation Hospital. Phase: NA. Conditions: Chronic Pain, Carpal Tunnel Syndrome
Sponsor: University of Rochester. Phase: NA. Conditions: Dry Eye Disease (DED)
Sponsor: Claire Bourgeois. Phase: PHASE4. Conditions: Shoulder Pain